The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $12.82 / share. This is an increase of 10.52% from the prior estimate of $11.60 dated November 14, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $10.10 to a high of $18.90 / share. The average price target represents an increase of 20.86% from the latest reported closing price of $10.61 / share.
What is the Fund Sentiment?
There are 351 funds or institutions reporting positions in Replimune Group. This is an decrease of 16 owner(s) or 4.36% in the last quarter. Average portfolio weight of all funds dedicated to REPL is 0.07%, an increase of 60.83%. Total shares owned by institutions increased in the last three months by 1.88% to 89,729K shares. 
The put/call ratio of REPL is 0.28, indicating a bullish outlook.
What are Other Shareholders Doing?
Baker Bros. Advisors holds 11,045K shares representing 14.08% ownership of the company. No change in the last quarter.
Price T Rowe Associates holds 8,306K shares representing 10.59% ownership of the company. In its prior filing, the firm reported owning 10,819K shares , representing a decrease of 30.25%. The firm decreased its portfolio allocation in REPL by 67.30% over the last quarter.
Rtw Investments holds 6,396K shares representing 8.15% ownership of the company. In its prior filing, the firm reported owning 2,065K shares , representing an increase of 67.71%. The firm increased its portfolio allocation in REPL by 20.85% over the last quarter.
PRNHX - T. Rowe Price New Horizons Fund holds 4,214K shares representing 5.37% ownership of the company. In its prior filing, the firm reported owning 4,666K shares , representing a decrease of 10.71%. The firm decreased its portfolio allocation in REPL by 7.65% over the last quarter.
Fcpm Iii Services B.v. holds 4,158K shares representing 5.30% ownership of the company. In its prior filing, the firm reported owning 3,910K shares , representing an increase of 5.98%. The firm decreased its portfolio allocation in REPL by 74.64% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
